Siloxane D5 Board of Review
Common menu bar links
Report of the Board of Review for Decamethylcyclopentasiloxane (Siloxane D5)
- Preface
- Terms and Abbreviations Used in this Report
- Executive Summary
- Statement of Reasons of the Siloxane D5 Board of Review
- The Nature, Use, Distribution, Concentrations, and Toxicity of Siloxane D5
- Assessment of the Nature and Extent of the Danger to the Environment Posed by Siloxane D5
- Conclusions of the Board of the Review
- Costs
- Strengths and Uncertainties
- Observations and Recommendations
- References
- Appendix A
- Appendix B
- Appendix C
- Appendix D
Report of the Siloxane D5 Board of Review (PDF; 817 KB)
1 Terms and Abbreviations Used in this Report
- Conclusions of the Board of Review
- Scope of the Mandate of the Board of Review
- Fate of Siloxane D5 in the Environment
- Exposure of Organisms in the Environment
- Bioaccumulation in Organisms
- Toxicity of Siloxane D5
- Risk Assessment
3 Statement of Reasons of the Siloxane D5 Board of Review
- 3.1 Introduction and Background
- 3.2 Procedural Steps in the Board of Review Process
- 3.3 Determination of Scope of the Board’s Mandate
- 3.4 Relevant Legislation and Regulations
- 3.5 Framing the Board’s Mandate
4 The Nature, Use, Distribution, Concentrations, and Toxicity of Siloxane D5
- 4.1 Use and Release of Siloxane D5 in the Canadian Environment
- 4.2 Distribution and Persistence of Siloxane D5 in the Environment
- 4.3 Persistence, Bioaccumulation and Trophic Magnification of Siloxane D5 in the Environment
- 4.4 Toxicity of Siloxane D5 to Receptor Organisms in the Environment
5 Assessment of the Nature and Extent of the Danger to the Environment Posed by Siloxane D5
- 5.1 Danger to Terrestrial Animals and Plants
- 5.2 Danger to Aquatic Organisms
- 5.3 Danger to Sediment-dwelling Organisms
- 5.4 Conclusions on the Nature and Extent of the Danger of Siloxane D5 to the Environment
6 Conclusions of the Board of the Review
9 Observations and Recommendations
- 9.1 Persistence and Bioaccumulation Regulations
- 9.2 Availability and Transparency of the Models
- 9.3 Conduct of Screening Assessments
Appendices
